Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials.
Liang Shi
No relevant relationships to disclose
Zhe Liu
No relevant relationships to disclose
Junfang Tang
No relevant relationships to disclose
Li Tong
No relevant relationships to disclose